ETHEMA HEALTH Corp
Qualité des données : 100%
GRST
OTC
Services
Health Services
0,00 €
▼
0,00 €
(-50,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
105,26%
Croissance
Revenue Growth (5Y)
105,26%
Au-dessus de la moyenne du secteur (4,21%)
Revenue (1Y)12,58%
Earnings (1Y)-315,21%
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC0,02%
Net Margin-9,34%
Op. Margin0,03%
Sécurité
Debt / Equity
N/A
Current Ratio0,18
Interest CoverageN/A
Valorisation
PE (TTM)
-1,61
En dessous de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDA7,24
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 105,26% annually over 5 years — strong growth
Earnings declined -315,21% over the past year
Negative free cash flow of -550 338,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 92,68%
Capital efficient — spends only 0,87% of revenue on capex
ROIC of 0,02% — low return on invested capital
Price History
Tendances Financières
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Growth
Rev 5Y: 105,26% · Earnings 1Y: -315,21%
Growth
Rev 5Y: 105,26% · Earnings 1Y: -315,21%| Revenue Growth (1Y) | 12,58% | Revenue Growth (3Y) | 11,72% |
| Earnings Growth (1Y) | -315,21% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 105,26% | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: -9,34%
Profitability
ROE: N/A · Net Margin: -9,34%| Revenue (TTM) | 15,42 M | Net Income (TTM) | -1,44 M |
| ROE | N/A | ROA | -4,87% |
| Gross Margin | N/A | Operating Margin | 0,03% |
| Net Margin | -9,34% | Free Cash Flow (TTM) | -550 338,0 |
| ROIC | 0,02% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 0,18
Safety
D/E: N/A · Current: 0,18| Debt / Equity | N/A | Current Ratio | 0,18 |
| Interest Coverage | N/A | Asset Turnover | 0,52 |
| Working Capital | -12,15 M | Tangible Book Value | -15,18 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -1,61 · EV/EBITDA: 7,24
Valuation
P/E: -1,61 · EV/EBITDA: 7,24| P/E Ratio | -1,61 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 0,15 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 7,24 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -23,74% | ||
| Market Cap | 2,32 M | Enterprise Value | 5,30 M |
Per Share
EPS: 0,00 · FCF/Share: 0,00
Per Share
EPS: 0,00 · FCF/Share: 0,00| EPS (Diluted TTM) | 0,00 | Revenue / Share | 0,00 |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 38,21% · CapEx/Rev: 0,87%
Efficiency
FCF Conv: 38,21% · CapEx/Rev: 0,87%| CapEx / Revenue | 0,87% | FCF Conversion | 38,21% |
| SBC-Adj. FCF | N/A | Growth Momentum | -92,68 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 6,02 M | 5,34 M | 4,82 M | 1,94 M | 338 996,0 |
| Net Income | -2,17 M | 1,01 M | 247 880,0 | -1,54 M | 3,08 M |
| EPS (Diluted) | 0,00 | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -1,33 M | -541 920,0 | 489 117,0 | 2 105,0 | -163 344,0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 466 952,0 | 498 919,0 | 540 119,0 | 325 350,0 | 121 276,0 |
| Interest Expense | — | — | — | -829 525,0 | 631 425,0 |
| Income Tax | -391 962,0 | 391 962,0 | -112 220,0 | -280 903,0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 12,16 M | 11,52 M | 6,56 M | 6,55 M | 3,82 M |
| Total Liabilities | 19,62 M | 17,72 M | 15,40 M | 16,01 M | 18,45 M |
| Shareholders' Equity | -7,46 M | -6,20 M | -10,10 M | -10,68 M | -15,73 M |
| Total Debt | 2,58 M | 680 672,0 | 460 534,0 | 122 167,0 | — |
| Cash & Equivalents | 244 771,0 | 68 573,0 | 140 757,0 | 48 822,0 | 90 500,0 |
| Current Assets | 528 758,0 | 403 100,0 | 542 896,0 | 271 799,0 | 935 152,0 |
| Current Liabilities | 9,65 M | 8,30 M | 13,29 M | 13,52 M | 13,86 M |
Comparaison Sectorielle
vs médiane du secteur Services (615 pairs)
Par rapport à des entreprises similaires dans Services
Comparaison Sectorielle
vs médiane du secteur Services (615 pairs) Par rapport à des entreprises similaires dans Services| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -1,6 | -1,2 |
| P/B | — | 1,4 |
| ROE % | — | -16,2 |
| Net Margin % | -9,3 | -19,4 |
| Rev Growth 5Y % | 105,3 | 4,2 |
| D/E | — | 0,4 |
Scores de Stratégies
1 strategy matched
Scores de Stratégies
1 strategy matched
#218 of 245
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"GRST","listing_kind":"stock","pathname":"/stocks/grst","exchange":"OTC","country":"US"}}